BRD4-specific PROTAC inhibits basal-like breast cancer partially through downregulating KLF5 expression
Ceshi Chen(Army Medical University), Yu Rao(Soochow University), Huang Haihui(Shenzhen Second People's Hospital), Chengang Zhou(Kunming Institute of Zoology), Wenxing Lv(Tsinghua University), Meng Zhang(Shanxi University), Dewei Jiang(Kunming Institute of Zoology), Xia Liu(Northwestern University), Chang Cai(Shenzhen Second People's Hospital), Wenfeng Peng(Shenzhen Second People's Hospital), Xiuyun Sun(Tsinghua University), Chuanyu Yang(Kunming Institute of Zoology), Yanjie Kong(Shenzhen Second People's Hospital), Xin Weng(Shenzhen Second People's Hospital), Luzhen Wang(Nanjing Forestry University), Tianlong Lan(Tsinghua University)
Cited by 0
Related Papers
PROTACs: great opportunities for academia and industry
|Signal Transduction and Targeted Therapy|2019|627
PROTAC Technology: Opportunities and Challenges
|ACS Medicinal Chemistry Letters|2020|353
Delta-secretase cleaves amyloid precursor protein and regulates the pathogenesis in Alzheimer’s disease
|Nature Communications|2015|280